MINIject Global Long-Term Follow-up Study

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DEVICE

Minimally invasive glaucoma surgery (MIGS)

MINIject implant placed into supraciliary space. The implantation was done in a previous study in which patient participated and is not part of this study.

Trial Locations (9)

38043

ACTIVE_NOT_RECRUITING

Center Hospotalier Universitaire Genoble Alpes, Grenoble

50937

ACTIVE_NOT_RECRUITING

Uniklinik Köln, Cologne

55131

ACTIVE_NOT_RECRUITING

Universitätsklinikum Mainz, Mainz

69417

ACTIVE_NOT_RECRUITING

Hopital de la Croix-Rousse, Lyon

81377

RECRUITING

Klinikum der Universität München, München

500034

RECRUITING

Maxivision Eye Hospital, Hyderabad

Unknown

RECRUITING

Clinica Oftalmologica del Caribe, Barranquilla

ACTIVE_NOT_RECRUITING

Panama Eye Center, Panama City

ACTIVE_NOT_RECRUITING

Hospital Clínico San Carlos, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

iSTAR Medical

INDUSTRY

NCT04524416 - MINIject Global Long-Term Follow-up Study | Biotech Hunter | Biotech Hunter